search
Back to results

Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery

Primary Purpose

Coronary Artery Disease, Physical Activity, Coronary Artery Bypass Graft Surgery

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Preoperative Exercise Training
Optimal medical therapy
Sponsored by
Kerckhoff Klinik
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Coronary Artery Disease focused on measuring Coronary Artery Bypass Graft Surgery, Physical Activity, Coronary Artery Disease, Physical Training

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • stable Angina
  • indication for elective CABG surgery
  • functional capacity > 50 watts
  • willingness to participate in the study

Exclusion Criteria:

  • unstable Angina
  • comorbidities precluding performance of aerobic exercise training (e.g. neurological disorders, orthopedic disorders etc)
  • functional Status NYHA IV
  • relevant ventricular arrhythmias
  • hemodynamic significant heart valve disease
  • myocarditis
  • cardiomyopathies
  • left main coronary artery disease > 50%
  • peripheral obstructive disease (Fontaine > IIb)
  • reduced life expectancy < 12 months
  • CABG surgery during the last six months
  • participation in another trial

Sites / Locations

  • Kerckhoff Klinik

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Training Group

Control Group

Arm Description

Preoperative Exercise Training Optimal medical therapy,

Optimal medical therapy, inactive control group

Outcomes

Primary Outcome Measures

Cardiopulmonary fitness
Change of maximal Oxygen consumption
Endothelial function
Change of Reactive hyperemic index (RHI)

Secondary Outcome Measures

Length of hospital stay (LoS)
Duration of hospital stay in days
Length of ventilation
Duration of Ventilation in minutes
Functional capacity
Change of 6-minute walk test
Arterial stiffness
Changes in arterial pulse wave analysis
Quality of life Questionnaire 1
Changes in MacNew (Heart Disease Health-related Quality of Life-) Questionnaire questionaire
Quality of life Questionnaire 2
Changes in Hospital Anxiety and Depression Scale (HADS) questionnaire: The HADS is a fourteen item scale that generates ordinal data.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
Quality of life Questionnaire 3
Changes in Mobility and Self-supply (MOSES) questionnaire
Ischemic blood marker 1
High Sensitive Troponin (hs-Trop)
Ischemic blood marker 2
Creatine kinase (CK) U/L
Ischemic blood marker 3
Creatine Kinase-MB (CK-MB) U/L
Ischemic blood marker 4
Lactate dehydrogenase (LDH) U/L
Ischemic blood marker 5
glutamic oxaloacetic transaminase (GOT) U/L
Ischemic blood marker 6
glutamate pyruvate transaminase (GPT) U/L
Ischemic blood marker 7
copeptin U/L
Inflammatory blood marker 1
C-reactive protein (CRP) U/L
Inflammatory blood marker 2
Leucozytes 10³/µL
Inflammatory blood marker 3
Interleukine-6 (IL-6) pg/mL
Number of patients with a Clinical Event
Atrial fibrillation documented by electrocardiogram (ECG)
Number of patients with a Pulmonary clinical event
Pleural effusion, pulmonary infection or other pulmonary disorder with Need for treatment
Number of patients with a Cardiovascular event
Revascularization, re-CABG, rehospitalization due to unstable angina, myocardial infarction
Number of patients with a Cerebrovascular event
TIA, stroke

Full Information

First Posted
March 21, 2018
Last Updated
September 30, 2019
Sponsor
Kerckhoff Klinik
search

1. Study Identification

Unique Protocol Identification Number
NCT04111744
Brief Title
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery
Official Title
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery- A Prospective Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
January 1, 2015 (Actual)
Primary Completion Date
June 30, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kerckhoff Klinik

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients (pts) with stable coronary artery disease (CAD) requiring coronary artery bypass graft surgery (CABG) may be physically inactive during the waiting period to avoid further risks. Aim of this study is to investigate the feasibility and safety of a preoperative aerobic exercise training in these pts during the waiting period and to analyze its effects on pre-, peri and postoperative outcomes
Detailed Description
Pts with stable coronary artery disease (CAD) and indication for elective CABG will be prospectively randomized into a preoperative training group (TG) or a non active control group (CG). Pts in TG have to perform six sessions of aerobic endurance training within two weeks prior to CABG. The following investigations will be performed at baseline, one day before surgery and at the beginning and at the end of cardiac rehabilitation: a maximal symptom limited ergospirometry, assessment of endothelial function (analysing the reactive hyperaemic index (RHI) via a finger-tonometry), assessment of quality of life (QoL) using the MacNew Heart Disease Questionnaire, laboratory testing of ischemic and inflammatory Parameters. Baseline, peri- and postoperative characteristics will be collected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Physical Activity, Coronary Artery Bypass Graft Surgery
Keywords
Coronary Artery Bypass Graft Surgery, Physical Activity, Coronary Artery Disease, Physical Training

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients enrolled to the study were randomised in a Treatment and a control Group
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
203 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Training Group
Arm Type
Experimental
Arm Description
Preoperative Exercise Training Optimal medical therapy,
Arm Title
Control Group
Arm Type
Other
Arm Description
Optimal medical therapy, inactive control group
Intervention Type
Other
Intervention Name(s)
Preoperative Exercise Training
Intervention Description
Patients undergoing CABG and randomized to the Training Group complete six sessions of aerobic endurance training prior CABG surgery
Intervention Type
Other
Intervention Name(s)
Optimal medical therapy
Intervention Description
Standard medication for stable CAD
Primary Outcome Measure Information:
Title
Cardiopulmonary fitness
Description
Change of maximal Oxygen consumption
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day ( postoperative day 7-14) , after 3 weeks of cardiac rehabilitation
Title
Endothelial function
Description
Change of Reactive hyperemic index (RHI)
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day (postoperative day 7-14), after 3 weeks of cardiac rehabilitation
Secondary Outcome Measure Information:
Title
Length of hospital stay (LoS)
Description
Duration of hospital stay in days
Time Frame
Within the acute care period
Title
Length of ventilation
Description
Duration of Ventilation in minutes
Time Frame
Within the acute care period
Title
Functional capacity
Description
Change of 6-minute walk test
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Arterial stiffness
Description
Changes in arterial pulse wave analysis
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Quality of life Questionnaire 1
Description
Changes in MacNew (Heart Disease Health-related Quality of Life-) Questionnaire questionaire
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Quality of life Questionnaire 2
Description
Changes in Hospital Anxiety and Depression Scale (HADS) questionnaire: The HADS is a fourteen item scale that generates ordinal data.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Quality of life Questionnaire 3
Description
Changes in Mobility and Self-supply (MOSES) questionnaire
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 1
Description
High Sensitive Troponin (hs-Trop)
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 2
Description
Creatine kinase (CK) U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 3
Description
Creatine Kinase-MB (CK-MB) U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 4
Description
Lactate dehydrogenase (LDH) U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 5
Description
glutamic oxaloacetic transaminase (GOT) U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 6
Description
glutamate pyruvate transaminase (GPT) U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Ischemic blood marker 7
Description
copeptin U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Inflammatory blood marker 1
Description
C-reactive protein (CRP) U/L
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Inflammatory blood marker 2
Description
Leucozytes 10³/µL
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Inflammatory blood marker 3
Description
Interleukine-6 (IL-6) pg/mL
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Number of patients with a Clinical Event
Description
Atrial fibrillation documented by electrocardiogram (ECG)
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Number of patients with a Pulmonary clinical event
Description
Pleural effusion, pulmonary infection or other pulmonary disorder with Need for treatment
Time Frame
Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Title
Number of patients with a Cardiovascular event
Description
Revascularization, re-CABG, rehospitalization due to unstable angina, myocardial infarction
Time Frame
after 30 days and 12 months
Title
Number of patients with a Cerebrovascular event
Description
TIA, stroke
Time Frame
after 30 days and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: stable Angina indication for elective CABG surgery functional capacity > 50 watts willingness to participate in the study Exclusion Criteria: unstable Angina comorbidities precluding performance of aerobic exercise training (e.g. neurological disorders, orthopedic disorders etc) functional Status NYHA IV relevant ventricular arrhythmias hemodynamic significant heart valve disease myocarditis cardiomyopathies left main coronary artery disease > 50% peripheral obstructive disease (Fontaine > IIb) reduced life expectancy < 12 months CABG surgery during the last six months participation in another trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claudia Walther, MD
Organizational Affiliation
Kerckhoff Clinic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Heike Baumgarten, MD
Organizational Affiliation
Kerckhoff Clinik
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kerckhoff Klinik
City
Bad Nauheim
ZIP/Postal Code
61231
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32546065
Citation
Steinmetz C, Bjarnason-Wehrens B, Baumgarten H, Walther T, Mengden T, Walther C. Prehabilitation in patients awaiting elective coronary artery bypass graft surgery - effects on functional capacity and quality of life: a randomized controlled trial. Clin Rehabil. 2020 Oct;34(10):1256-1267. doi: 10.1177/0269215520933950. Epub 2020 Jun 16.
Results Reference
derived

Learn more about this trial

Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery

We'll reach out to this number within 24 hrs